Articles

Meeting the rising demand for biologics Biologics have revolutionized the medical landscape with their targeted mechanisms of action and potential for treating a wide array of indications. As the global population grapples with an increasing burden of disease, including cancer and chronic conditions, he demand for effective biologics has surged, propelling the biopharmaceutical industry into an...

  Scaling biologics for commercial: The importance of adopting a customer-centric approach In this blog, Bora outlines the key challenges biologics developers face on the journey towards commercialization and highlights the importance of finding a development and manufacturing partner adopting a customer-centric approach to overcome scaling issues. Scaling challenges in the dynamic biologic...

In pharmaceutical contract manufacturing, outsourcing your product to the right Contract Development and Manufacturing Organization (CDMO) can be a daunting and concerning task. After conducting the legwork of determining the best fit for a CDMO from capabilities and organizational fit perspective, the next step is working with that vendor on determining costs. Generally speaking, there is a ton...

How can Bora Biologics help to support your next biologics project? Having a robust Cell Line Development (CLD) strategy is the foundation of biologic production that can propel a project, helping to streamline production while mitigating risk. A tailored and optimized cell line can be instrumental in overcoming development and manufacturing challenges and achieving a competitive advantage in...